News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Flowers Cynthia Louise
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Flowers Cynthia Louise (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $2.83, valued at
$84.9k
|
|
| 01/11/2023 |
4
| Flowers Cynthia Louise (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2022 |
4
| Flowers Cynthia Louise (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 11/09/2021 |
4
| Flowers Cynthia Louise (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Gifted 20,150 shares
@ $0
Disposed/sold 10,850 shares
@ $9.5, valued at
$103.1k
Disposed/sold 64,935 options to buy
@ $2.27, valued at
$147.4k
Disposed/sold 100,000 options to buy
@ $2.29, valued at
$229k
Disposed/sold 85,034 options to buy
@ $4.44, valued at
$377.6k
Disposed/sold 96,975 options to buy
@ $3.58, valued at
$347.2k
|
|
| 06/21/2021 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 4,389 shares
@ $0
Granted 19,620 options to buy
@ $21.97, valued at
$431.1k
|
|
| 05/13/2021 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 96,975 options to buy
@ $3.58, valued at
$347.2k
|
|
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $17.59, valued at
$351.8k
|
|
| 05/14/2020 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 85,034 options to buy
@ $4.44, valued at
$377.6k
|
|
| 03/12/2020 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Bought 9,307 shares
@ $3.235, valued at
$30.1k
Bought 21,693 shares
@ $3.24, valued at
$70.3k
|
|
| 01/14/2020 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 18,292 restricted stock units
@ $3.28, valued at
$60k
|
|
| 06/14/2019 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $18.47, valued at
$369.4k
|
|
| 05/16/2019 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.29, valued at
$229k
|
|
| 01/23/2019 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 64,935 options to buy
@ $2.27, valued at
$147.4k
|
|
| 01/23/2019 |
3
| Schwalm Cynthia (Director) has filed a Form 3 on Kadmon Holdings, Inc. |
| 01/16/2019 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 12,121 restricted stock units
@ $4.95, valued at
$60k
|
|
| 12/27/2018 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Bought 1,420 shares
@ $18.4482, valued at
$26.2k
|
|
| 06/11/2018 |
4
| Schwalm Cynthia (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $38.39, valued at
$767.8k
|
|
| 06/11/2018 |
3
| Schwalm Cynthia (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
|
|